Cardiovascular Considerations for Hydroxyzine and Amlodipine Co-Prescription

Cardiovascular Risks

• Amlodipine, as a dihydropyridine calcium channel blocker (DHP-CCB), can cause significant blood pressure reduction, which may be exacerbated when combined with hydroxyzine, increasing the risk of orthostatic hypotension, falls, and syncope, especially in elderly patients 1
• The combination of hydroxyzine and amlodipine may increase the risk of orthostatic hypotension, falls, and syncope, especially in elderly patients 1

Monitoring and Patient Management

• The American Heart Association recommends monitoring blood pressure closely during the first 3 months of therapy, as this is when the most potent blood pressure-lowering effects of amlodipine occur 1
• Elderly patients are at higher risk for adverse effects due to decreased hepatic and overall clearance of both medications, according to the American College of Cardiology 1

Patient-Specific Considerations

• Patients with heart failure require special consideration, as amlodipine is one of the few calcium channel blockers that can be safely used in heart failure patients, as stated by the European Society of Cardiology 2, 3
• Patients with renal impairment may require dose adjustments, as drug clearance may be affected, as recommended by the National Kidney Foundation 1

Dosing and Drug Interactions

• The American College of Cardiology recommends starting with lower doses of both medications when used concomitantly and titrating doses cautiously, especially in elderly patients 1
• Amlodipine may inhibit clopidogrel metabolism, which is an important consideration in patients on antiplatelet therapy, according to the American Heart Association 1

Alternative Therapies

• For hypertension management, the American Heart Association suggests considering other antihypertensives that may have fewer interactions with hydroxyzine, such as ACE inhibitors or ARBs 4, 5